PubRank

G F Lewis

Author PubWeight™ 34.45‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Deterioration in renal function associated with fibrate therapy. Clin Nephrol 2001 2.92
2 Prolonged elevation of plasma free fatty acids impairs pancreatic beta-cell function in obese nondiabetic humans but not in individuals with type 2 diabetes. Diabetes 2000 1.52
3 Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 2000 1.46
4 A molecular Einstein ring: imaging a starburst disk surrounding a quasi-stellar object. Science 2003 1.38
5 Triglyceride enrichment of HDL enhances in vivo metabolic clearance of HDL apo A-I in healthy men. J Clin Invest 1999 1.35
6 Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation. Am J Physiol 1999 1.30
7 Prolonged elevation of plasma free fatty acids desensitizes the insulin secretory response to glucose in vivo in rats. Diabetes 1999 1.22
8 Portal venous and enteric exocrine drainage versus systemic venous and bladder exocrine drainage of pancreas grafts: clinical outcome of 40 consecutive transplant recipients. Ann Surg 2000 1.14
9 Differential effects of monounsaturated, polyunsaturated and saturated fat ingestion on glucose-stimulated insulin secretion, sensitivity and clearance in overweight and obese, non-diabetic humans. Diabetologia 2006 1.12
10 HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 1999 1.12
11 Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance. Trends Cardiovasc Med 2001 1.09
12 Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 1999 1.01
13 The effect of systemic versus portal insulin delivery in pancreas transplantation on insulin action and VLDL metabolism. Diabetes 2001 0.98
14 Oral taurine but not N-acetylcysteine ameliorates NEFA-induced impairment in insulin sensitivity and beta cell function in obese and overweight, non-diabetic men. Diabetologia 2007 0.98
15 Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Diabetologia 2011 0.96
16 Prolonged increase of plasma non-esterified fatty acids fully abolishes the stimulatory effect of 24 hours of moderate hyperglycaemia on insulin sensitivity and pancreatic beta-cell function in obese men. Diabetologia 2004 0.94
17 Chronic exogenous insulin and chronic carbohydrate supplementation increase de novo VLDL triglyceride fatty acid production in rats. J Lipid Res 1997 0.93
18 Hypoglycemic thresholds for cognitive dysfunction in humans. Diabetes 1990 0.92
19 A stable isotope method using a [(2)H(5)]glycerol bolus to measure very low density lipoprotein triglyceride kinetics in humans. J Lipid Res 1999 0.91
20 Hyperinsulinemia and triglyceride-rich lipoproteins. Diabetes 1996 0.86
21 Role of basal triglyceride and high density lipoprotein in determination of postprandial lipid and lipoprotein responses. J Clin Endocrinol Metab 1992 0.86
22 Effect of increased plasma non-esterified fatty acids (NEFAs) on arginine-stimulated insulin secretion in obese humans. Diabetologia 2001 0.85
23 Apolipoprotein B-48 and retinyl palmitate are not equivalent markers of postprandial intestinal lipoproteins. J Lipid Res 1998 0.85
24 Elevated plasma lipids in patients with binge eating disorders are found only in those who are anorexic. Int J Eat Disord 1999 0.84
25 Hypoglycemic thresholds for cognitive dysfunction in IDDM. Diabetes 1992 0.84
26 Correction of hyperandrogenemia by laparoscopic ovarian cautery in women with polycystic ovarian syndrome is not accompanied by improved insulin sensitivity or lipid-lipoprotein levels. J Clin Endocrinol Metab 1999 0.82
27 Lipid metabolism. Curr Opin Lipidol 1999 0.80
28 Analysis of particle size and lipid composition as determinants of the metabolic clearance of human high density lipoproteins in a rabbit model. J Lipid Res 1998 0.79
29 Postprandial lipoprotein metabolism in diabetes mellitus and obesity. J Atheroscler Thromb 1995 0.77
30 Beta-blockade, but not normoglycemia or hyperinsulinemia, markedly diminishes stress-induced hyperglycemia in diabetic dogs. Diabetes 2000 0.77
31 The effects of cerebral white matter changes on cardiovascular responses to cognitive and physical activity in a stroke population. Psychophysiology 2012 0.77
32 Important contribution of lipoprotein particle number to plasma triglyceride concentration in type 2 diabetes. Atherosclerosis 1998 0.77
33 Carotid intima-media thickness in type 2 diabetes is more strongly related to serum apoprotein A-I in females. Wien Klin Wochenschr 2001 0.77
34 Atherosclerosis prevention for the next decade: risk assessment beyond low density lipoprotein cholesterol. Can J Cardiol 1998 0.76
35 Triglyceride enrichment of HDL does not alter HDL-selective cholesteryl ester clearance in rabbits. J Lipid Res 2001 0.76
36 An epitaph for sulfated insulin: immunologic profile of the last patients as they are switched from sulfated beef to human insulin. Diabetes Care 1998 0.75
37 Lipid metabolism. Curr Opin Lipidol 1998 0.75
38 Serum creatinine level is an independent risk factor for the angiographic severity of internal carotid artery stenosis in subjects who have previously had transient ischaemic attacks. J Cardiovasc Risk 1998 0.75
39 Short-term effects of early programming for the young gifted handicapped child. Except Child 1983 0.75